NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hologen

Hologen

Private
LondonHealthcare & Life Scienceshttps://hologen.ai/

Last Round

Series A

Jan 28, 2026

Est. Valuation

$1B

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hologen is an AI biotechnology company that develops multi-modal generative AI models to improve the understanding, design, evaluation, and delivery of treatments for neurological and other complex health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Foundation

Keywords

large medicine modelsLMMgenerative AIdrug discoverybiotech AIclinical trial optimizationfoundation modelmultimodal AIprecision medicinein silico drug designclinical data integrationAI drug discoveryreal-world evidencetherapeutic developmentAI biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hologen Comparables

Compare Hologen with similar companies based on industry and business-model similarity.

Hologen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Hologen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 28, 2026
VC RoundNov 27, 2025
SeedJul 1, 2025

Key People

Founding team and executive leadership

Chris Goddard

CTO Co-founder

Founding Team

M. Jorge Cardoso

Co-Founder Chief AI Officer

Founding Team

Dean Worrall

Chief Financial Officer

Executive Team

Hologen Investors

Notable investors and investment history

Hologen investors
InvestorRounds
2468 VenturesSeed
SW7 GroupSeed
UCL BusinessSeed
Meridian Health VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Grew 36% QoQ, from 25 to 34 employees.

  • May 17, 2026

    Monthly visitors increased 39% MoM, reaching 4K.

Hologen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hologen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hologen's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range34
Year Founded2023
Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.